Company intelligence / Profile preview

AJICO

San Diego, California, United Statesjvcmusic.co.jp ↗

Ownership: Private
Employees: ~1000
Development stage: Other

Overview

Ajinomoto Bio‑Pharma Services provides global contract development and manufacturing services for small molecules, large molecules, oligonucleotides, peptides, antibody-drug conjugates, and gene therapies. They support projects from preclinical through commercial scale using proprietary platform technologies such as AJIPHASE®, CORYNEX®, and AJICAP®. Their facilities are located in Belgium, United States, Japan, and India. The company manufactures medicines for cancer, genetic disorders, various organ-specific conditions, and vaccines for infectious disease.

Therapeutic areas: OncologyPulmonologyRare DiseasesGastroenterologyCardiovascularOphthalmologyInfectious Diseases
Modalities: Small moleculeLarge moleculeOligonucleotidePeptideAntibody-drug conjugateGene therapy
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on AJICO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AJICO.

Explore the full profile